Artax Biopharma Inc Cambridge, MA - 02142

Artax Biopharma Inc is categorized under Wholesale Pharmaceutical Products in Cambridge, MA and active since 2013.

Artax Biopharma Inc was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Dami Tormo at the company’s single location by writing to 1 Broadway Floor 14, Cambridge, Massachusetts MA 02142 or by phoning (617) 401-2168. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Artax Biopharma Inc
Contact Person: Dami Tormo
Address: 1 Broadway Floor 14, Cambridge, Massachusetts 02142
Phone Number: (617) 401-2168
Website Address: artaxbiopharma.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Artax Biopharma Inc was started in 2013 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Dami Tormo for inquiries that concern Artax Biopharma Inc by calling the company number (617) 401-2168, as your correspondence is most welcome. Additionally, the physical location of the single location of Artax Biopharma Inc can be found at the coordinates 42.362362,-71.083313 as well as the street address 1 Broadway Floor 14 in Cambridge, Massachusetts 02142.

For its online presence, you may visit Artax Biopharma Inc’s website at artaxbiopharma.com and engage with its social media outlets through on Twitter and on Facebook.